TY - JOUR
T1 - MRI of Arterial Flow Reserve in Patients with Intermittent Claudication: Feasibility and Initial Experience
AU - Versluis, Bas
AU - Dremmen, Marjolein H. G.
AU - Nelemans, Patty J.
AU - Wildberger, Joachim E.
AU - Schurink, Geert-Willem
AU - Leiner, Tim
AU - Backes, Walter H.
PY - 2012/3/8
Y1 - 2012/3/8
N2 - Objectives: The aim of this work was to develop a MRI method to determine arterial flow reserve in patients with intermittent claudication and to investigate whether this method can discriminate between patients and healthy control subjects. Methods: Ten consecutive patients with intermittent claudication and 10 healthy control subjects were included. All subjects underwent vector cardiography triggered quantitative 2D cine MR phase-contrast imaging to obtain flow waveforms of the popliteal artery at rest and during reactive hyperemia. Resting flow, maximum hyperemic flow and absolute flow reserve were determined and compared between the two groups by two independent MRI readers. Also, interreader reproducibility of flow measures was reported. Results: Resting flow was lower in patients compared to controls (4.9 +/- 1.6 and 11.1 +/- 3.2 mL/s in patients and controls, respectively (p
AB - Objectives: The aim of this work was to develop a MRI method to determine arterial flow reserve in patients with intermittent claudication and to investigate whether this method can discriminate between patients and healthy control subjects. Methods: Ten consecutive patients with intermittent claudication and 10 healthy control subjects were included. All subjects underwent vector cardiography triggered quantitative 2D cine MR phase-contrast imaging to obtain flow waveforms of the popliteal artery at rest and during reactive hyperemia. Resting flow, maximum hyperemic flow and absolute flow reserve were determined and compared between the two groups by two independent MRI readers. Also, interreader reproducibility of flow measures was reported. Results: Resting flow was lower in patients compared to controls (4.9 +/- 1.6 and 11.1 +/- 3.2 mL/s in patients and controls, respectively (p
U2 - 10.1371/journal.pone.0031514
DO - 10.1371/journal.pone.0031514
M3 - Article
C2 - 22412836
SN - 1932-6203
VL - 7
JO - PLOS ONE
JF - PLOS ONE
IS - 3
M1 - e31514
ER -